| |
|
|
|
DiaMedica Therapeutics Inc.  
|
|
5.73 -0.07 (-0.01%) |
07-14 13:59 |
|
Open: |
5.59 |
Pre close: |
5.8 |
Target:
|
8.34
|
|
High: |
5.7543 |
Low: |
5.41 |
Resistance:
|
7.14
8.80
|
|
Volume: |
16,597 |
Market Cap: |
81M |
Support:
|
4.45
3.70
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.23
 |
MACD |
MACD(12,26):
|
0.26 |
|
MA(20): |
6.58  |
Signal(12,26,9): |
0.47 |
|
MA(100): |
4.42 |
Stochastic Oscillator |
%K(14,3):
|
5.67 |
|
MA(250): |
3.80 |
%D(3): |
17.37 |
|
Average Volume(K) |
3-Month: |
7805
|
52-Week |
High:
|
8.80 |
|
10-Days: |
4200 |
Low: |
1.70 |
|
RSI |
RSI(14):
|
41.85 |
Change(%): |
45.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.800 |
Return on Equity (ttm) |
-72.1 |
Shares Out. (M) |
14.14 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-44.3 |
Shares Float (M) |
10.67 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
9.04 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
20.26 |
|
Forward EPS |
-0.740 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
20 |
|
Book Value (p.s.) |
0.940 |
EBITDA (p.s.) |
-0.746 |
P/E |
-7.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.96 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.95 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.95 |
P/CF |
-8.85 |
|
|
|
|
|
|
